Trading Policy Restrictions. Option exercises and other Awards under the Plan shall be subject to the Company’s insider trading policies and procedures, as in effect from time to time.
Galecto, Inc. (GLTO) (CIK 0001800315)
Source: SEC EDGAR database • Date: March 29, 2021 • SIC: 2834 • CIK: 2834
aTYR PHARMA INC (LIFE) (CIK 0001339970)
Source: SEC EDGAR database • Date: May 8, 2020 • SIC: 2836 • CIK: 2836
Paramount Group, Inc. (PGRE) (CIK 0001605607)
Source: SEC EDGAR database • Date: May 17, 2021 • SIC: 6798 • CIK: 6798
HUBSPOT INC (HUBS) (CIK 0001404655)
Source: SEC EDGAR database • Date: February 16, 2021 • SIC: 7372 • CIK: 7372
FATE THERAPEUTICS INC (FATE) (CIK 0001434316)
Source: SEC EDGAR database • Date: March 5, 2018 • SIC: 2836 • CIK: 2836
Eidos Therapeutics, Inc. (EIDX) (CIK 0001731831)
Source: SEC EDGAR database • Date: August 1, 2019 • SIC: 2834 • CIK: 2834
aTYR PHARMA INC (LIFE) (CIK 0001339970)
Source: SEC EDGAR database • Date: May 10, 2019 • SIC: 2836 • CIK: 2836
FATE THERAPEUTICS INC (FATE) (CIK 0001434316)
Source: SEC EDGAR database • Date: March 2, 2020 • SIC: 2836 • CIK: 2836
Sage Therapeutics, Inc. (SAGE) (CIK 0001597553)
Source: SEC EDGAR database • Date: November 6, 2018 • SIC: 2834 • CIK: 2834